| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Dec 06, 2022 | Dec 10, 2022 | Glickman Mark A Co-CEO | Sell | Therapeuticsmd, Inc. | TXMD | $4.92 | $2,165 | -25.37% |
| Mar 19, 2018 | Mar 21, 2018 | Glickman Mark A Chief Commercial Officer | Sell | Aralez Pharmaceuticals Inc. | ARLZ | $1.7 | $9,733 | -2.24% |
| May 16, 2016 | May 18, 2016 | Glickman Mark A Chief Commercial Officer | Buy | Aralez Pharmaceuticals Inc. | ARLZ | $3.68 | $92,050 | +11.82% |
| Nov 20, 2014 | Nov 24, 2014 | Glickman Mark A EVP - Sales Marketing | Sell | Auxilium Pharmaceuticals Inc | AUXL | $33.17 | $2M | -63.21% |